Hepatic Arterial Embolization for the Treatment of Metastatic Neuroendocrine Tumors
Neuroendocrine tumors (NETs) have a high predilection for metastasizing to the liver and can cause severe debilitating symptoms adversely affecting quality of life. Although surgery remains the treatment of choice, many liver metastases are inoperable at presentation. Hepatic arterial embolization p...
Saved in:
Main Authors: | Eric Lee, H. Leon Pachter, Umut Sarpel |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | International Journal of Hepatology |
Online Access: | http://dx.doi.org/10.1155/2012/471203 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Ace of Spades: Reverse Takotsubo Cardiomyopathy in the Context of Angiographic Embolization of Recurrent Metastatic Serotonin-Positive Neuroendocrine Tumour of the Pancreas
by: Ian A. Mazzetti, et al.
Published: (2013-01-01) -
Treatment of Liver Metastases in Patients with Neuroendocrine Tumors
by: Dan Granberg, et al.
Published: (2012-01-01) -
Radioembolization in the Treatment of Neuroendocrine Tumor Metastases to the Liver
by: Martin Vyleta, et al.
Published: (2011-01-01) -
Primary Hepatic Neuroendocrine Tumor with Unusual Thyroid Follicular-Like Morphologic Characteristics
by: Mohd Elmugtaba Ibrahim, et al.
Published: (2017-01-01) -
Clinical manifestations of coronary artery embolism due to heart tumors
by: R.M. Vitovsky, et al.
Published: (2021-10-01)